FDA Inspection 1115356 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.

Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. — FEI 3001047110

The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on January 15, 2020 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 15, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)